Hong Kong stocks surged, with the Hang Seng Index hitting a three-year high!
Alibaba launched a new reasoning model yesterday, and the AI agent Manus went viral overnight. Here's a quick look at the popular China-concept AI stocks.
Yidu Tech Inc., an investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People’s Rep...
Yidu Tech reversed an early gain and closed 6.90% lower at HK$2.160, sliding from a HK$2.320 open and a HK$2.310 morning high to a HK$2.120 afternoon low at 13:28 BJ, within 1.9% of the 52-week low of HK$2.12 set only the previous session, on 5.54 million shares. The move extends a run of record lows, including a 12.78% weekly decline, even as the company scheduled a board meeting to review interim results, appointed Fan Wenhui as an independent non-executive director, and its affiliate won a RMB 13.29 million hospital data platform contract plus RMB 14.9 million of infectious-disease AI projects in Xi'an. Fundamentals contrast with the tape: Q4 2026 revenue rose 26.87% year on year to HK$262.1 million and net profit climbed 224.56% to HK$49.6 million at an 18.93% margin. Yet the stock is down 59.63% year to date, 69.36% below its HK$7.05 52-week high and under both MA20 (2.767) and MA60 (3.26), with PB at 0.53. Whether that earnings recovery converts into durable cash flow still awaits the interim numbers.
Yidu Tech reversed early gains, opening at HK$2.530 before sliding to an intraday HK$2.290, a fresh listing low, and closing at HK$2.325, down 5.5% on about HK$10.7 million turnover, as investors stayed cautious ahead of the board meeting to review interim results, while the appointment of Fan Wenhui as an independent non-executive director offered little support. The shares sit roughly 17% below the MA20 of HK$2.804 and 29% below the MA60 of HK$3.297, down 56.5% year to date, 67% below the 52-week high of HK$7.05 and only 1.5% above the 52-week low. Fundamentals contrast sharply: Q4 2026 revenue rose 26.9% year on year to HK$262.1 million and net profit jumped 224.6% to HK$49.6 million, with an 18.93% net margin and a 0.57 price-to-book. Still, an affiliate's recent wins of a RMB13.29 million hospital data platform contract and RMB14.9 million of infectious-disease AI projects in Xi'an have yet to feed through to the share price.
Yidu Tech opened at HK$2.61 and sold off through the session to close at HK$2.46, down about 6.1%, with an intraday slide from HK$2.59 to HK$2.435 that hit the 52-week low as selling pressure near record levels extended the recent run of declines. The move contrasts with Q4 2026 revenue of HK$262.1 million, up 26.87% year on year, net profit of HK$49.6 million, up 224.56%, an 18.93% net margin and operating profit of HK$17.4 million, up 119.62%; the shares remain 65.11% below the HK$7.05 52-week high, down 54.02% year to date and under both the HK$2.832 MA20 and HK$3.328 MA60. The company scheduled a board meeting to review interim results, while an affiliate won a RMB13.29 million hospital data platform contract and RMB14.9 million of Xi'an infectious-disease AI projects, though these updates did not prevent the afternoon slide to the low.
Yidu Tech reversed early gains, touching HK$2.915 at the 09:30 morning open before sliding to HK$2.650 by 15:38 in the afternoon session and closing at HK$2.660, down 7.64% from the prior HK$2.880 close and at a fresh 52-week low. It is now 50.28% lower year-to-date, 62.27% below its 52-week high of HK$7.05, and sits under its MA20 of HK$2.894. Sentiment was weighed by the company's failure to disclose a US$65 million secured loan facility with Goldman Sachs, on top of earlier single-day drops of 5% and 6% and a week in which it lagged the Hang Seng Index. That contrasts with Q4 revenue of HK$262.1 million, up 26.87% year-on-year, net profit of HK$49.6 million, up 224.56%, and an affiliate's RMB 13.29 million win for a big-data platform at the First Affiliated Hospital of Chongqing Medical University. Turnover was thin at 0.28%, leaving disclosure issues and improving fundamentals pulling against each other.
Yidu Tech fell 3.52% to HK$2.875, opening at HK$2.960 and dipping to HK$2.805 before recovering through the afternoon, as disclosure concerns weighed: the company had not disclosed a US$65 million Goldman Sachs secured loan facility constituting an advance to an entity, and the stock had already lost about 6% in a single session two days earlier. Fundamentals contrast with the tape — Q4 revenue rose 26.87% year on year to HK$262.1 million and net profit jumped 224.56% to HK$49.6 million, while an affiliate won a new-generation big data platform contract at the First Affiliated Hospital of Chongqing Medical University worth RMB13.29 million and the company serves as primary operator of Beijing's inclusive health insurance scheme for a sixth year. The shares remain weak: down 46.26% year to date, 59.22% below the 52-week high of HK$7.05, and under the MA20 of HK$2.919 and MA60 of HK$3.45, though a 0.71x price-to-book offers some cushion.
Yidu Tech hits record low in Hong Kong trading
Weekly Recap | YIDU TECH -12.78%, repeatedly hitting record lows
Yidu Tech falls nearly 6% in Hong Kong trading
Yidu Tech Schedules Board Meeting to Review Interim Results
Yidu Tech Files List of Board and Committee Members
Alibaba launched a new reasoning model yesterday, and the AI agent Manus went viral overnight. Here's a quick look at the popular China-concept AI stocks.
